PriceTracker GLP-1

Insurance coverage · verified October 2026

Does Aetna cover Mounjaro for weight loss?

It depends on your plan

your employer's plan design decides, not the insurer's name

Prior auth: required

Aetna's Mounjaro-specific prior-authorisation policy (5468-C) is still a diabetes policy throughout: approval turns on a type 2 diabetes diagnosis plus either metformin failure, intolerance or contraindication, or needing combination therapy with an A1C of 7.5 percent or higher, with quantity limits. On the 2026 Standard Control Plan drug guide Mounjaro sits as a preferred brand. Weight loss is off-label for Mounjaro, but Aetna's weight-loss policy, reissued in April 2026, now names Mounjaro among its target drugs and judges tirzepatide requests (Zepbound or Mounjaro) on the same criteria: age 18 or over, at least 6 months in a comprehensive weight-management programme, and a baseline BMI of 35 or higher. That route only exists on plans whose employer has bought the weight-management drug benefit; the same drug guide warns that your plan may not cover weight-loss drugs at all. Zepbound, the same molecule approved for weight, is a preferred brand on the Standard Control drug guide dated 1 October 2026.

The facts

Weight loss

Plan-dependent

Type 2 diabetes

Yes, with PA

Prior auth

Required

Typical cost

Plan-specific

Who actually decides this

Not the logo on your card, most of the time. Three parties sit between you and the answer, and knowing which one is saying no tells you who to ask.

  1. 1

    The pharmacy benefit manager

    No single PBM to name here, which is itself the finding. Different plans under this name use different benefit managers, so one national statement about the formulary would be wrong.

  2. 2

    Your employer, if the plan comes through work

    Weight-loss drugs are usually a category an employer buys or declines, not something the insurer includes by default. That is why two people holding identical cards get opposite answers, and why the useful question for member services is whether your plan includes the weight-loss medication benefit at all, before anything about criteria.

Get your real answer

For diabetes, have your prescriber submit Aetna's Mounjaro prior authorisation with the diagnosis and your metformin history, then confirm the tier price with the Check Drug Cost and Coverage tool at caremark.com. If weight is the goal, first ask member services (number on your Aetna ID card) whether your plan includes the weight-management drug benefit; if it does, Aetna's weight-loss policy applies to tirzepatide under either brand name, and Zepbound has been a preferred brand on the Standard Control formulary since 1 October 2026, so read the Zepbound answer too and check your plan.

Coverage is plan-specific: this page reports what Aetna publishes, not a promise about your plan. Not medical or insurance advice.

What it actually costs you

If your plan covers it

The manufacturer savings card is the lever, and it is worth being precise about what it does: it takes up to $100 a month off your copay. It does not set your price to $25. You reach the advertised $25 only if your copay is roughly $125 or less, so on a $300 copay the card leaves you paying $200.

The Mounjaro card, and what the cap does to your number →

If you are on Medicare, Medicaid or TRICARE For Life

The card is closed to you. Every manufacturer savings card in this category excludes government beneficiaries, and that is deliberate rather than an oversight you can argue around. The Medicare GLP-1 Bridge, at $50 a month, is the route worth asking about by name.

What Medicare covers, and what the Bridge does not count toward →

If the answer is no, or you have no plan

A copay card needs a copay to work on, so with no coverage it does nothing. That leaves the manufacturer’s own cash prices, the discount cards, and the compounded market, which is cheaper again and not FDA-approved. We priced all of them against each other.

Every route without insurance, priced →Whether GoodRx helps here →

All four manufacturers cap their cards differently. The caps compared side by side.

The receipts

Every claim on this page traces to Aetna’s own published material or a primary document, quoted verbatim, with the date we read it.

1
“Authorization may be granted for a diagnosis of type 2 diabetes mellitus when the following criteria is met … The patient has experienced an inadequate treatment response, intolerance, or has a contraindication to metformin … The patient requires combination therapy AND has an A1C of 7.5 percent or greater”

https://www.aetna.com/products/rxnonmedicare/data/2025/GIP-GLP-1_Agonist_Mounjaro_PA_with_Limit_Policy_5468-C_UDR_05-2024.html · 2024-10-27

2
“QUANTITY LIMITS APPLY 4 single-dose pens or single-dose vials (2 mL) per 21 days”

https://www.aetna.com/products/rxnonmedicare/data/2025/GIP-GLP-1_Agonist_Mounjaro_PA_with_Limit_Policy_5468-C_UDR_05-2024.html · 2024-10-27

3
“MOUNJARO SUBCUTANEOUS SOLUTION AUTO- INJECTOR 10 MG/0.5ML, 12.5 MG/0.5ML, 15 MG/0.5ML, 2.5 MG/0.5ML, 5 MG/0.5ML, 7.5 MG/0.5ML (tirzepatide) PB”

https://fm.formularynavigator.com/FBO/41/2026_Standard_Control_Plan.pdf · 2026-10-01

4
“Weight Loss (BMI 35) GIP-GLP-1, GLP-1 Agonists … FOUNDAYO (orforglipron) … MOUNJARO (tirzepatide) … SAXENDA (liraglutide) … WEGOVY (semaglutide) … WEGOVY HD (semaglutide) … ZEPBOUND (tirzepatide)”

https://www.aetna.com/products/rxnonmedicare/data/2026/Weight_Loss_(BMI%2035)_GIP-GLP-1,_GLP-1_Agonists_PA_with_Limit_6450-C_P08-2025_v8.html · 2026-04-10

5
“The patient is 18 years of age or older. The patient has participated in a comprehensive weight management program that encourages behavioral modification, reduced-calorie diet, AND increased physical activity with continuing follow-up for at least 6 months prior to using drug therapy. The patient has a baseline body mass index (BMI) greater than or equal to 35 kg/m 2 .”

https://www.aetna.com/products/rxnonmedicare/data/2026/Weight_Loss_(BMI%2035)_GIP-GLP-1,_GLP-1_Agonists_PA_with_Limit_6450-C_P08-2025_v8.html · 2026-04-10

6
“Your plan may not cover certain drugs to treat conditions such as infertility, erectile dysfunction and weight loss.”

https://fm.formularynavigator.com/FBO/41/2026_Standard_Control_Plan.pdf · 2026-10-01

7
“You can choose to customize your benefits to include or exclude GLP-1 drug coverage for weight management.”

https://www.aetna.com/employers-organizations/glp1-benefits-coverage.html · 2026-10-04

Common questions

Does Aetna cover Mounjaro for weight loss?

It depends on your specific plan rather than on the Aetna name. Weight-loss drugs are usually a category your employer buys or declines, so two people holding Aetna cards can get opposite answers.

Does Aetna cover Mounjaro for type 2 diabetes?

Yes, with PA. Diabetes is the indication plans cover far more readily than weight management, so if you have a type 2 diagnosis the answer is usually yes with prior authorisation, even where weight-loss coverage is excluded.

Do I need prior authorization for Mounjaro with Aetna?

Required. Your prescriber submits it with the documentation the policy asks for, which for weight-management requests usually means a BMI threshold and a period of documented lifestyle or behavioural change.

Can I use a Mounjaro coupon with Aetna?

If you have commercial insurance, the Mounjaro savings card takes up to $100 a month off your copay rather than setting your price to $25, so you reach the advertised figure only if your copay is roughly $125 or less. If you are on Medicare, Medicaid or TRICARE For Life, every manufacturer card in this category excludes government beneficiaries and the card is closed to you.

What if Aetna will not cover Mounjaro?

Cash-pay is the fallback and it is cheaper than most people expect. The cheapest verified tirzepatide program we track is $69 a month at SnagRx, with no insurance involved. Compounded programs are not FDA-approved, which is the trade-off to weigh against the price.

Coverage changes. We watch it.

Formularies move every year, and so do prices. Check your own insurer, or get the weekly price email.

Check your insurer